Fact-checked by Grok 2 weeks ago

Cardiac conduction system

The cardiac conduction system is a specialized of cells within the heart that generates electrical impulses and coordinates the rhythmic contractions of the atria and ventricles to ensure efficient pumping of blood. This system comprises key components including the sinoatrial (SA) node, atrioventricular (AV) node, , bundle branches, and , which together form an intrinsic and conduction pathway independent of external neural input, though modulated by the . The SA node, located in the upper right atrium near the , serves as the primary by spontaneously depolarizing at a rate of 60-100 times per minute, initiating atrial and propagating the impulse across both atria via internodal pathways. The electrical signal then reaches the AV node, situated at the base of the right atrium within the triangle of Koch near the , where it is delayed for approximately 0.1 seconds to allow complete atrial emptying before ventricular filling. From the AV node, the impulse travels through the , which penetrates the fibrous between the atria and ventricles, and divides into left and right bundle branches that course along the . The bundle branches terminate in an extensive Purkinje fiber network that ramifies through the ventricular myocardium, rapidly distributing the wave to synchronize ventricular from to , achieving a conduction up to 4 meters per second—far faster than in ordinary myocardial cells. This coordinated sequence ensures atrial precedes ventricular , optimizing , and the system's activity can be monitored noninvasively via (ECG) to detect rhythm disorders such as or arrhythmias. Dysfunctions in this system, often due to aging, ischemia, or , can lead to conduction blocks or ectopic pacemakers, underscoring its critical role in maintaining cardiovascular .

Anatomy and development

Structural components

The sinoatrial (SA) node is a crescent-shaped structure located subepicardially in the right atrium at the junction with the , with its tail extending 10-20 mm along the . Its intramural architecture features a central body approximately 15 mm long and 4 mm wide, with radiating projections toward the terminal crest, pectinate muscles, and , enclosed partly by myocardium and epicardial fat. The node consists of specialized nodal cells organized into central and peripheral zones, including pacemaker (P) cells that are small, ovoid, and pale-staining with sparse myofibrils, and transitional (T) cells that bridge to atrial myocardium. These P cells exhibit fewer myofibrils and fewer gap junctions compared to surrounding contractile myocytes, supporting while allowing controlled impulse transmission to the atria. The atrioventricular (AV) node resides at the apex of the triangle of Koch in the right atrium, positioned posterior to the septal leaflet of the and adjacent to the ostium. It comprises a compact nodal portion (N region) of small, pale cells with low expression, transitioning to the penetrating portion that extends anteriorly through the central fibrous body, and the nodo-His region with mixed profiles. Histologically, AV nodal cells are smaller than contractile myocytes, with reduced myofibrils and low expression, contributing to slow conduction and electrical isolation from adjacent atrial tissue. The emerges as the continuation of the node's penetrating portion, traversing the fibrous to bifurcate into the right and left bundle branches on the . The right bundle branch forms a narrow, ribbon-like tract descending along a septal trabeculation, while the left bundle branch spreads as a broad, trifascicular sheet (anterior, posterior, and septal fascicles) across the left septal . These branches connect to an extensive network, which ramifies as fine, low-density strands on the ventricular endocardial surfaces, denser on the left side in a cone-like distribution toward the and papillary muscles. consist of elongated cells with fewer myofibrils and abundant gap junctions relative to contractile ventricular myocytes, optimizing conduction velocity. Interatrial synchronization is supported by specialized tracts, including internodal pathways from the SA node along the and , and Bachmann's bundle, a prominent muscular band of parallel myocardial strands crossing the anterior interatrial groove from right to left atrium. These structures feature aligned cardiomyocytes with enhanced density compared to ordinary atrial myocytes, aiding efficient spread of impulses.

Embryological origins

The cardiac conduction system originates during early embryogenesis from the cardiac crescent, a mesodermal structure that forms around the third week of (approximately day 21-23 in humans), which gives rise to the primary heart tube and initiates rhythmic contractions through peristaltic waves. This primitive conduction begins with the primordial atrium serving as the initial , transitioning to the as the heart tube elongates and loops between weeks 3 and 4. By the end of week 3, precursors of the conduction system are specified within the myocardial wall of the heart tube, setting the stage for regional differentiation into and conductive tissues. The sinoatrial (SA) node develops from tissues of the right common cardinal vein and , which incorporate into the right atrium during heart looping around week 5. These venous pole structures express early markers like Hcn4 and Tbx3, forming the mature SA node that becomes the primary in the adult heart. In contrast, the atrioventricular () node and His bundle derive from the AV canal myocardium and associated , which undergo epithelial-to-mesenchymal transformation to contribute to the insulating annulus fibrosus and conductive axis by weeks 5-7. The AV canal's slow-conducting properties persist in the AV node, ensuring timed ventricular activation. Purkinje fibers emerge later, during mid-to-late fetal stages (around weeks 8-10), through differentiation and migration from the subendocardial ventricular myocardium, guided by epicardial-mesenchymal interactions involving epicardium-derived cells. These cells secrete factors that promote Purkinje network expansion across the ventricles, forming a rapid-conducting subendocardial meshwork. Specification of the conduction system is tightly regulated by transcription factors such as Tbx5 and Nkx2.5, which promote AV bundle and Purkinje fiber development while repressing chamber-like gene expression in conductive tissues. Signaling pathways, including Wnt (which inhibits Nkx2.5 to maintain SA node identity) and Notch (which drives Purkinje differentiation via Bmp10 upregulation), further refine these lineages during heart tube maturation. Disruptions in these processes can lead to congenital anomalies, such as Wolff-Parkinson-White syndrome from genetic mutations (e.g., PRKAG2 in humans) causing accessory pathways, or persistent left superior vena cava altering SA node positioning and function.

Physiology

Action potential mechanisms

The action potential in cells of the cardiac conduction system, particularly pacemaker cells, differs from that in contractile myocardial cells, enabling spontaneous electrical activity essential for initiating heartbeats. In pacemaker cells such as those in the sinoatrial (SA) node and atrioventricular (AV) node, the action potential consists of three main phases, lacking the distinct early (phase 1) and plateau (phase 2) seen in ventricular myocytes. Phase 0 involves rapid , but unlike the fast sodium-driven upstroke in working myocardium, it relies primarily on calcium influx through L-type calcium channels, resulting in a slower upstroke of approximately 10-20 V/s compared to 200-500 V/s in ventricular cells. Phase 3 is driven by efflux, while phase 4 is characterized by spontaneous diastolic , which progressively brings the to the threshold for the next , conferring to these cells. This phase 4 is mediated by the "funny" current (I_f), a hyperpolarization-activated mixed sodium- inward current, alongside contributions from calcium clock mechanisms involving calcium release. Key differences between pacemaker and working myocardial action potentials arise from distinct ion channel expression and function. cells exhibit low expression of the Kir2.1, which underlies the stable (I_{K1}) in ventricular myocytes, preventing a true resting phase and allowing phase 4 drift. In and nodal cells, phase 0 depends on L-type calcium channels (Cav1.2) rather than voltage-gated sodium channels (Nav1.5), which are sparsely expressed or inactivated at nodal diastolic potentials, leading to slower conduction and reduced excitability compared to the rapid, sodium-mediated propagation in atrial or ventricular tissue. The hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, particularly HCN4 in the node, conduct I_f, activating upon hyperpolarization at the end of to initiate phase 4 with slow kinetics that contribute to the timing of subsequent beats. These mechanisms establish a of among conduction system components, ensuring the SA node dominates rhythm generation under normal conditions. The SA node exhibits the fastest intrinsic firing rate of 60-100 beats per minute, followed by the AV node at 40-60 beats per minute, and at 20-40 beats per minute, with dominance determined by the steepest phase 4 slope reaching threshold first. This hierarchy relies on graded differences in I_f density and activation kinetics, with higher HCN expression and faster diastolic depolarization in the SA node.

Propagation and synchronization

The electrical impulse in the heart originates in the sinoatrial (SA) and propagates through a specialized conduction pathway to ensure coordinated contraction. From the SA , the impulse travels rapidly across the atria via internodal pathways, depolarizing the atrial myocardium and leading to atrial . The impulse then reaches the atrioventricular () , where it is briefly delayed to allow complete atrial emptying, before proceeding through the His bundle, which divides into left and right bundle branches. These branches further ramify into the Purkinje fiber network, distributing the impulse swiftly to the ventricular myocardium for synchronized ventricular contraction. Efficient propagation along this pathway relies on low-resistance electrical coupling between cardiomyocytes, primarily mediated by gap junctions composed of proteins. In the atria and conduction system, connexin 40 (Cx40) predominates, forming channels that support rapid intercellular current flow, while connexin 43 (Cx43) is more abundant in the ventricular working myocardium, ensuring reliable signal transmission. These gap junctions create a functional , minimizing conduction delays and maintaining the integrity of the impulse as it traverses from specialized tissues to contractile cells. Synchronization of atrial and ventricular contractions is critical for optimal , with atrial preceding ventricular to enhance ventricular filling during late . This "atrial kick" contributes approximately 20-30% of ventricular , stretching myocardial fibers and invoking the Frank-Starling mechanism, whereby increased preload augments contractile force. Disruptions in this timing could impair filling and reduce , underscoring the conduction system's role in temporal coordination. Conduction velocities vary along the pathway to achieve this: atrial tissue conducts at about 0.4 m/s, sufficient for orderly atrial activation, while the Purkinje system achieves 2-4 m/s, enabling near-simultaneous ventricular from to . The conduction system also maintains dominance of the primary pacemaker through overdrive suppression, where faster rhythmic activity from the SA node inhibits subsidiary pacemakers. This occurs via hyperpolarization of the in slower foci during accelerated firing, temporarily raising their threshold for spontaneous and preventing ectopic rhythms. Such a mechanism ensures stable control under normal conditions.

Electrophysiology

Atrial depolarization and SA node

The sinoatrial (SA) node serves as the primary of the heart, initiating the through its intrinsic . Located at the junction of the and the right atrium, the SA node generates spontaneous action potentials that propagate as an electrical wavefront across the atria, coordinating their contraction prior to ventricular activation. This process ensures efficient atrial emptying and sets the rhythm for the entire heart, typically at a rate of 60-100 beats per minute in adults under normal conditions. The electrical activity originating from the SA node manifests on the electrocardiogram (ECG) as the , which represents the of the atrial myocardium. Normally, the P wave has a of 80-100 and an of less than 2.5 in the limb leads, reflecting the rapid and synchronous spread of the wavefront from the right to the left atrium. This wavefront is facilitated by preferential conduction pathways in the atrial myocardium, sometimes described in anatomical studies as internodal tracts—including the anterior internodal tract (extending from the anterior margin of the SA node around the to Bachmann's bundle), the middle internodal tract (also known as Wenckebach's tract, running along the ), and the posterior internodal tract (coursing posteriorly near the )—though their existence as specialized structures composed of clusters of conducting fibers remains debated, with electrophysiological evidence supporting efficient conduction via ordinary atrial fibers. Although the SA node dominates under normal circumstances, ectopic atrial foci—abnormal sites of within the atrial myocardium—can potentially override it if they exhibit a faster firing rate. Such foci, often located near the pulmonary veins or , may suppress SA node activity and assume pacemaker control, leading to rhythms like ectopic when their rate exceeds that of the sinus node. Histologically, the high of SA node cells arises from their specialized structure, including sparse expression of the inward rectifier current (IK1) channels, which reduces hyperpolarization after and allows for gradual diastolic . These cells are smaller, with fewer myofibrils and a higher of mitochondria compared to working atrial myocytes, supporting their role in spontaneous impulse generation.

AV conduction and delay

The atrioventricular (AV) node, located at the base of the , serves as the primary site for delaying the cardiac impulse originating from the , ensuring sequential atrial and ventricular contraction. This AV nodal conduction time is approximately 50-120 ms, allowing for complete atrial and emptying of blood into the ventricles before ventricular activation begins, optimizing ventricular preload and . On the electrocardiogram (ECG), the —encompassing intra-atrial conduction, nodal conduction time, and initial His bundle activation—is measured from the onset of the (atrial ) to the start of the (ventricular ), with a normal duration of 120-200 ms. A prolonged exceeding 200 ms indicates first-degree block, reflecting slowed conduction through the node without impulse blockage. Conduction decrements at the AV node manifest as second-degree AV blocks, including Wenckebach (Mobitz I) and Mobitz II types. In Mobitz I, the progressively lengthens with each successive beat until a P wave fails to conduct, resulting in a dropped ; this pattern typically arises within the AV node and is often benign, associated with high . In contrast, Mobitz II features a constant with abrupt non-conducted P waves, usually originating in the infranodal His-Purkinje system and carrying a higher risk of progression to complete . Following the AV nodal conduction, the impulse rapidly propagates through the His-Purkinje system, a specialized network of fibers including the , bundle branches, and , which conducts at high speeds (up to 4 m/s) to synchronize ventricular . This efficient distal conduction ensures near-simultaneous of the ventricular myocardium, minimizing dyssynchrony. AV nodal conduction is modulated by the , with sympathetic stimulation via beta-adrenergic receptors accelerating impulse transmission by enhancing calcium influx and shortening the refractory period, thereby reducing the . Conversely, parasympathetic (vagal) input slows conduction through of the IK,ACh potassium current, prolonging the action potential and increasing the delay, which can exacerbate blocks during heightened .

Ventricular activation and repolarization

Ventricular activation begins following the atrioventricular delay, with the electrical impulse traveling from the bundle branches into the , a subendocardial system of specialized conducting cells that rapidly distributes the wavefront across the ventricular myocardium. This network ensures near-simultaneous activation from to epicardium, optimizing synchronized contraction and by minimizing dyssynchrony. The facilitate this by conducting at velocities up to 4 m/s, far exceeding the 0.5-1 m/s of myocardial cells, allowing for efficient propagation despite the ventricles' large mass. On the electrocardiogram (ECG), ventricular manifests as the , a series of deflections typically lasting less than 120 ms in duration under normal conditions. The sequence of activation proceeds from the (initial leftward Q wave), to the apical regions of both ventricles (prominent R wave reflecting bulk myocardial ), and finally to the basal portions ( as the wavefront reaches the upper ventricles). This septal-to-apical-to-basal progression, driven by the Purkinje system's arborization, ensures coordinated ventricular contraction from apex toward base, promoting effective blood ejection. Ventricular repolarization follows depolarization and is represented by the on the ECG, which typically peaks 200-300 ms after the QRS complex onset, corresponding to the recovery of the myocardial cells to their resting state. The 's polarity—usually upright in most leads—reflects the repolarization sequence, where epicardial cells recover earlier than endocardial cells, creating a opposite to depolarization; this transmural gradient results in a positive deflection as the recovery wavefront moves from epicardium to endocardium. The entire process of ventricular electrical activity, from depolarization onset to repolarization completion, is captured by the , measured from the start of the Q wave to the end of the . To account for heart rate variations, the corrected QT interval (QTc) is calculated using Bazett's formula: QTc = QT / √RR, where RR is the interval between consecutive R waves in seconds, allowing standardized assessment of repolarization duration. Disruptions in the conduction pathway, such as bundle branch blocks, alter ventricular activation and prolong the beyond 120 ms. In (RBBB), the right ventricle is activated belatedly via transseptal spread from the left, producing an rsR' pattern in right precordial leads (V1-V2) and wide S waves in lateral leads. (LBBB), conversely, delays left ventricular activation, resulting in broad, notched R waves in lateral leads (I, aVL, V5-V6) and absent septal Q waves, with secondary ST-T changes discordant to the QRS direction. These blocks desynchronize ventricular contraction, potentially impairing , though isolated RBBB often has less clinical impact than LBBB.

Clinical significance

Arrhythmias

Arrhythmias arising from the cardiac conduction system disrupt the normal generation and propagation of electrical impulses, leading to irregular heart rhythms that can compromise and cause symptoms such as syncope, fatigue, or hemodynamic instability. These disorders primarily involve abnormalities in the sinoatrial () node, atrioventricular () node, His-Purkinje system, or their interconnecting pathways, resulting in bradyarrhythmias, tachyarrhythmias, or conduction delays. The immediate clinical impacts include reduced to vital organs, increased risk of in atrial arrhythmias, and potential progression to life-threatening events like . Sinus node dysfunction, also known as sick sinus syndrome, manifests as impaired SA node pacemaker activity or impulse transmission, leading to severe ( <50 bpm), sinus pauses exceeding 3 seconds, or sinoatrial exit block. In this condition, failure of pacemaker cells (P cells) or transitional cells (T cells) due to structural degeneration disrupts the heart's primary rhythm generator, causing chronotropic incompetence where the heart cannot adequately increase rate in response to physiologic demands. A common variant, tachy-brady syndrome, involves alternating bradycardia and paroxysmal supraventricular tachyarrhythmias like atrial fibrillation, affecting over 50% of patients and exacerbating symptoms through erratic rhythm transitions. Clinically, these lead to cerebral hypoperfusion, manifesting as dizziness or presyncope, with an annual incidence of associated AV block ranging from 0% to 4.5%. AV blocks represent interruptions in conduction from atria to ventricles, with second-degree and third-degree (complete heart block) forms being particularly relevant to conduction system pathology. Second-degree AV block type II features constant PR intervals with intermittent non-conducted P waves, often originating infranodally in the His-Purkinje system, while high-grade variants involve multiple consecutive dropped beats. Third-degree AV block results in complete dissociation between atrial and ventricular activity, with no impulses traversing the , forcing reliance on subsidiary pacemakers. Escape rhythms emerge to maintain ventricular rate: junctional escapes from the AV node (rate 40-60 bpm, narrow QRS) or ventricular escapes from (rate 20-40 bpm, wide QRS) if junctional fails, but these slower rates often cause bradycardia-induced symptoms like hypotension and fatigue. The immediate impacts include irregular pulses, dyspnea, and risk of syncope due to inadequate cardiac output. Bundle branch blocks and fascicular blocks constitute intraventricular conduction delays within the His-Purkinje system, prolonging QRS duration and altering ventricular activation sequence. Right or left bundle branch block interrupts impulse flow in respective branches, causing sequential rather than simultaneous ventricular depolarization (QRS >0.12 seconds), while fascicular blocks affect anterior or posterior left fascicles, leading to axis deviation and milder QRS widening (<0.12 seconds). These delays arise from slowed or blocked conduction in the specialized fibers, often progressing to bifascicular or trifascicular involvement in extensive damage. Clinically, they are typically but signal underlying structural disease, increasing vulnerability to complete AV block and reducing synchrony, which impairs ventricular efficiency and elevates cardiac event risk, particularly in . Supraventricular tachycardias (SVT) linked to the conduction system, such as atrioventricular nodal reentrant (AVNRT), arise from re-entry circuits within or adjacent to the AV node. AVNRT, the most common SVT (50-60% of cases), involves dual AV nodal pathways—a fast and slow conduit—enabling a reentrant loop where anterograde conduction occurs via the slow pathway and retrograde via the fast, producing rapid rates (118-264 ) with near-simultaneous atrial and ventricular activation. Typical slow-fast AVNRT predominates (90%), while atypical fast-slow variants reverse the pathways. These tachycardias cause , chest discomfort, and due to abrupt hemodynamic shifts, with potential for tachycardia-mediated if sustained. Ventricular arrhythmias originating in the conduction system include premature ventricular contractions () and (VT) driven by Purkinje fiber abnormalities. PVCs are ectopic impulses from distal Purkinje sites, often triggered by delayed afterdepolarizations from calcium dysregulation in remodeled fibers post-infarction or in . VT via Purkinje re-entry forms macro-reentrant circuits involving surviving Purkinje remnants and scarred myocardium, perpetuated by slowed conduction and unidirectional block in the His-Purkinje network. These arrhythmias manifest as or hemodynamic collapse, with PVCs initiating VT/VF storms in vulnerable substrates, heightening risk in structural heart disease. Key risk factors for these conduction-related arrhythmias include ischemia, which induces electrical instability through oxidative stress and reperfusion injury, promoting re-entry in the Purkinje system. Fibrosis, prevalent in aging and heart failure, replaces conduction tissue with scar, depressing velocity and creating heterogeneous substrates for block and re-entry, particularly in the atria and nodes. Electrolyte imbalances, such as hyperkalemia, prolong conduction by elevating resting membrane potential and reducing excitability, leading to widened QRS, AV block, and ventricular arrhythmias via slowed His-Purkinje propagation.

Diagnostic and therapeutic interventions

Diagnostic methods for assessing cardiac conduction system function primarily include (ECG), studies (EPS), and advanced imaging techniques. The 12-lead ECG serves as the cornerstone for evaluating conduction intervals, such as PR, QRS, and QT durations, enabling the identification of abnormalities like or through non-invasive surface recordings. monitoring via Holter ECG extends this assessment by capturing intermittent conduction disturbances over 24-48 hours, particularly useful for detecting paroxysmal bradyarrhythmias or tachyarrhythmias in dynamic settings. EPS involves invasive catheter-based to measure conduction velocities, localize re-entry circuits, and provoke arrhythmias under controlled conditions, providing precise localization of conduction defects such as pathways or slow pathway involvement in supraventricular tachycardias. This technique is indicated for risk stratification in patients with syncope or structural heart disease, with high sensitivity for identifying inducible circuits. Echocardiography complements these by revealing structural correlates to conduction abnormalities, such as valvular disease or chamber enlargement impacting the conduction pathways, through real-time visualization of myocardial motion and strain. Cardiac (MRI) excels in detecting within conduction tissues, using late enhancement and T1 mapping to quantify extracellular volume expansion, which correlates with slowed conduction and arrhythmogenic substrates in conditions like . These imaging modalities are particularly valuable in unexplained conduction disease, where MRI identifies infiltrative processes in up to 30% of cases with preserved . Therapeutic interventions target conduction disorders through and device-based or procedural approaches. Beta-blockers, such as metoprolol, are first-line for supraventricular tachycardias involving enhanced or re-entry, by prolonging atrioventricular nodal refractoriness and reducing sympathetic drive on the conduction system. Antiarrhythmic agents are classified into Vaughan-Williams classes I-IV, with Class I (e.g., ) slowing conduction in atrial or ventricular tissues, Class III potassium channel modulators (e.g., ) prolonging to prevent re-entry, and Class IV antagonists (e.g., verapamil) targeting nodal tissues. These drugs modulate ion channels directly affecting conduction velocity and excitability, though proarrhythmic risks necessitate ECG monitoring. For bradyarrhythmias due to sinoatrial or dysfunction, pacemaker implantation restores physiologic conduction by delivering paced impulses, with dual-chamber devices preferred to maintain atrioventricular synchrony and prevent . is curative for focal re-entrant arrhythmias like atrioventricular nodal reentrant tachycardia (AVNRT), targeting the slow pathway with radiofrequency energy to eliminate dual nodal physiology, achieving success rates over 95% while minimizing risks like transient . In (VT), ablation maps and ablates scar-related circuits, often guided by , reducing recurrence by 70-80% in structural heart disease. Recent advances emphasize conduction-preserving therapies and molecular interventions. His-bundle pacing, a selective site pacing technique, directly activates the intrinsic conduction system distal to the , improving ventricular synchrony compared to traditional right ventricular pacing and reducing progression in patients with conduction delays. Clinical adoption has grown since 2020, with multicenter trials demonstrating lower pacing thresholds and better long-term outcomes in bradycardic patients. trials for channelopathies, such as or catecholaminergic polymorphic VT, have progressed post-2020 using adeno-associated viral vectors to deliver corrective genes (e.g., or RYR2), showing restored conduction and reduced inducibility in preclinical models and initial early-phase human trials. For instance, in July 2025, the FDA granted fast track designation to SGT-501, an AAV-based for CPVT, with first-in-human trials planned for late 2025. These approaches target genetic defects in conduction proteins, with ongoing phase I/II trials assessing safety and preliminary efficacy in restoring normal based on preclinical data.

References

  1. [1]
    Cardiac conduction system - Health Video - MedlinePlus
    Oct 15, 2024 · A network of specialized muscle cells is found in the heart's walls. These muscle cells send signals to the rest of the heart muscle causing a contraction.
  2. [2]
    Overview of Cardiac Conduction - Conduction System Tutorial
    Though the primary function of the atrioventricular node may seem simple, that is to relay conduction between the atria and ventricles, its structure is very ...
  3. [3]
    Cardiovascular System: Cardiac Conduction System
    The cardiac conduction system comprises nodes and pathways that conduct electrical impulses in the heart. The sinoatrial (SA) node acts as the pacemaker which ...
  4. [4]
    The Cardiac Conduction System | Circulation
    Mar 1, 2011 · The functional components of the CCS can be broadly divided into the impulse-generating nodes and the impulse-propagating His-Purkinje system.
  5. [5]
    High resolution 3-Dimensional imaging of the human cardiac ...
    Aug 3, 2017 · We present, in attitudinally appropriate fashion, the first 3-dimensional representations of the cardiac conduction system within the intact human heart.The Sinus Node And Its... · The Atrioventricular... · The Bundle Branches And...
  6. [6]
    The sinoatrial node, a heterogeneous pacemaker structure
    In the human and dog, in the centre of SA node, there are characteristic 'P' cells (or 'typical nodal' cells), which are believed to be the leading pacemaker ...<|control11|><|separator|>
  7. [7]
    Conduction system of the heart: Parts and Functions | Kenhub
    The increased number of gap junctions allow more ions to pass from one cell to the next, thus increasing the rate of conduction. Furthermore, there are fewer ...
  8. [8]
  9. [9]
    Conduction tissue - Pathology Outlines
    Dec 1, 2015 · Conduction tissue · Cells include nodal cells, transitional cells and atrial muscle cells · Nodal cells (P cells) are small ovoid, pale staining ...
  10. [10]
    Bachmann's Bundle | Circulation: Arrhythmia and Electrophysiology
    Oct 1, 2013 · Bachmann's bundle (BB), also known as the interatrial bundle, is well recognized as a muscular bundle comprising of parallel aligned myocardial strands ...
  11. [11]
    Embryology of the Conduction System for the Electrophysiologist
    Aug 15, 2010 · In this article, we briefly review the relevant stages of cardiac development for electrophysiologists.
  12. [12]
    Development of the Cardiac Conduction System - PMC
    This review describes in detail the transcriptional and regulatory networks that act during cardiac conduction system development and homeostasis with a ...
  13. [13]
    Cardiac Ion Channels | Circulation: Arrhythmia and Electrophysiology
    Apr 1, 2009 · This review describes the generation of the normal cardiac action potential. The properties of the major ionic currents are the examined in detail.The Cardiac Action Potential · Sodium Channels · Potassium Channels
  14. [14]
    Physiology, Cardiac Muscle - StatPearls - NCBI Bookshelf
    Unlike the cardiac muscle cells, the pacemaker cells' action potential is divided into 3 phases instead of 5, as phases 1 and 2 are absent.
  15. [15]
    The Role of the Funny Current in Pacemaker Activity
    Feb 19, 2010 · The degree of activation of the funny current determines, at the end of an action potential, the steepness of phase 4 depolarization; hence, the ...
  16. [16]
    Cardiac ion channels - PMC - NIH
    The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium.Sodium Channels · Calcium Channels · Inward Rectifying Potassium...
  17. [17]
    HCN Channels and Heart Rate - PMC - PubMed Central - NIH
    Hyperpolarization and Cyclic Nucleotide (HCN) -gated channels represent the molecular correlates of the “funny” pacemaker current (If), a current activated ...
  18. [18]
    Physiology, Cardiac Repolarization Dispersion and Reserve - NCBI
    Apr 17, 2023 · The myocardiocyte action potential is different from that of pacemaker cells and has five phases, zero through four. Phase 0 is the phase of ...
  19. [19]
    Mechanisms of cardiac arrhythmias - PMC - PubMed Central - NIH
    The cardiac action potential results from the sequential opening and closing of ion channel proteins that span the plasma membrane of individual myocytes. Its ...4. Focal Activity · 5. Reentry · 5.1. Reentry Involving An...<|control11|><|separator|>
  20. [20]
    Hyperpolarization-Activated Current, I f, in Mathematical Models of ...
    A typical feature of sinoatrial (SA) node pacemaker cells is the presence of an ionic current that activates upon hyperpolarization.
  21. [21]
    Gene Regulatory Networks in Cardiac Conduction System ...
    The cardiac impulse is initiated in the SAN and propagates through the atria. The electric impulse is then delayed in the AVN before rapid conduction through ...<|separator|>
  22. [22]
    Role of Gap Junctions in Cardiac Conduction and Development
    Cx43 is the only connexin known to be expressed in the adult working myocardium, although a recent report suggests that Cx37 (α6 connexin) also may be present.
  23. [23]
    Cardiac gap junction channels: modulation of expression and ...
    The third connexin, Cx40, is strongly co-expressed with Cx43 in the working myocardium of the atria (except in rat).3.2 Cx43 Channel Properties · 3.4 From Transfected Cells... · 5.2 Ischemic Heart Disease...
  24. [24]
    The Cardiac Cycle and the Physiological Basis of Left Ventricular ...
    Late in diastole, atrial contraction increases the atrial pressure, producing a second atrial-to-LV pressure gradient that again propels blood into the LV.
  25. [25]
    Physiology, Frank Starling Law - StatPearls - NCBI Bookshelf
    The Frank-Starling relationship is the observation that ventricular output increases as preload (end-diastolic pressure) increases.Missing: synchronization | Show results with:synchronization
  26. [26]
    Purkinje Fibers and Arrhythmias - PMC - NIH
    The conduction velocity of electrical impulses is much higher in Purkinje fibers (2–3 m/s) than in myocardial cells (0.3–0.4 m/s). The fast propagation is ...Missing: sources | Show results with:sources
  27. [27]
    Overdrive Suppression - CV Physiology
    The higher frequency of SA nodal firing suppresses other pacemaker sites by a mechanism called overdrive suppression.
  28. [28]
    The relationship among cardiac pacemakers. Overdrive suppression.
    A short stimulation at high frequency (10-. 100 impulses/sec) applied directly to the sinus node led to hyperpolarization, temporary suppression of pacemaker.
  29. [29]
    Physiology, Sinoatrial Node - StatPearls - NCBI Bookshelf
    It is believed to involve the perinodal (T) cells. Similar to sinus pause and arrest, the atria do not receive the proper signal to contract, and thus, the ECG ...
  30. [30]
    Prevalence and relation to training of electrocardiographic findings ...
    Training frequently induces electrocardiographic (ECG) changes that mimic heart diseases, requiring specific criteria for interpretation.
  31. [31]
    Surgical and Electrical Anatomy of the Inter-Nodal and Intra-Atrial ...
    Three routes are described in this paper; anterior (#1), middle (#2), and posterior (#3). Branches of the route are described by adding sub-numbers to the route ...
  32. [32]
    Differential Distribution of Cardiac Ion Channel Expression as a ...
    This article reviews the major regionally determined features of cardiac electrical function, discusses underlying ionic bases, and summarizes present knowledge
  33. [33]
    Atrioventricular Block - StatPearls - NCBI Bookshelf
    Feb 12, 2024 · Atrioventricular block represents a delay or disturbance in the transmission of an impulse from the atria to the ventricles.
  34. [34]
    Normal and Abnormal Electrical Conduction - CV Physiology
    The bundle branches then divide into an extensive system of Purkinje fibers that conducts the impulses at high velocity (about 4 m/sec) throughout the ...Missing: 0.4 sources
  35. [35]
    Second-Degree Atrioventricular Block - StatPearls - NCBI Bookshelf
    Mobitz type I (Wenckebach) is often a normal variant and seen in individuals with a high vagal tone without evidence of structural heart disease. However, this ...
  36. [36]
    Conducting System of the Heart - Bundle of His - SA Node - TeachMeAnatomy
    ### Summary of His-Purkinje System's Role in Rapid Conduction After AV Node
  37. [37]
    Role of the Autonomic Nervous System in Modulating Cardiac ...
    Mar 14, 2014 · The autonomic nervous system plays an important role in the modulation of cardiac electrophysiology and arrhythmogenesis.
  38. [38]
    Heart Conduction System (Cardiac Conduction) - Cleveland Clinic
    The Purkinje fibers to your ventricles (bottom heart chambers), which causes them to contract and deliver blood out to your body. Advertisement. These steps ...
  39. [39]
    Ion Channel Subunit Expression Changes in Cardiac Purkinje Fibers
    Apr 9, 2009 · Conduction through the His-Purkinje system is an important determinant of the sequence of ventricular activation and contraction. Cardiac ...
  40. [40]
    Conquering the ECG - Cardiology Explained - NCBI Bookshelf
    QRS wave complex. The three waves of the QRS complex represent ventricular depolarization. For the inexperienced, one of the most confusing aspects of ECG ...Electrocardiography · Depolarization of the heart · The ECG trace
  41. [41]
    Changing Activation Sequence in the Embryonic Chick Heart
    The main finding of the present study is that the mature ventricular apex-to-base activation sequence begins between stages 29 and 31, a period in heart ...
  42. [42]
    Electrocardiographic T Wave and its Relation With Ventricular ...
    May 16, 2014 · The T wave on the ECG (T-ECG) represents repolarization of the ventricular myocardium. Its morphology and duration are commonly used to ...
  43. [43]
    Corrected QT Interval (QTc) - MDCalc
    Corrects the QT interval for heart rate extremes (choose from Bazett, Fridericia, Framingham, Hodges, or Rautaharju formulas).
  44. [44]
    Left Bundle Branch Block - StatPearls - NCBI Bookshelf
    Oct 5, 2024 · LBBB appears as a widened QRS complex with certain characteristic features on electrocardiography, described below.
  45. [45]
    Sick Sinus Syndrome - StatPearls - NCBI Bookshelf - NIH
    Sick sinus syndrome, also known as sinus node dysfunction, is a disorder of the sinoatrial node caused by impaired pacemaker function and impulse transmission.Continuing Education Activity · Etiology · Pathophysiology · History and Physical
  46. [46]
    Sinus Node Dysfunction - StatPearls - NCBI Bookshelf
    Sinus node dysfunction is a disease that is characterized by the inability of the sinoatrial node of producing an adequate heart rate that meets the physiologic ...
  47. [47]
    Sinus node dysfunction: current understanding and future directions
    Sinus node dysfunction (SND) is due to abnormalities within the SAN, which can affect the heartbeat frequency, regularity, and the propagation of electrical ...
  48. [48]
    Bundle Branch Block and Fascicular Block - Cardiovascular Disorders
    The conduction delay may occur beyond the Purkinje fibers and result from slow cell-to-cell myocyte conduction. Risk of subsequent cardiac events and mortality ...Missing: pathophysiology | Show results with:pathophysiology
  49. [49]
    Common Types of Supraventricular Tachycardia: Diagnosis ... - AAFP
    Oct 15, 2010 · AVNRT and AVRT are electrical aberrancies that occur mainly as a result of reentry. Less commonly, increased automaticity or triggered activity ...
  50. [50]
    Ventricular Arrhythmias Involving the His-Purkinje System in the ...
    Perturbation of the His-Purkinje system can lead to life-threatening ventricular arrhythmias, including ventricular tachycardia (VT) or ventricular fibrillation ...
  51. [51]
    Premature Ventricular Complexes - Medscape Reference
    Sep 2, 2024 · Ventricular premature complexes (VPCs) are ectopic impulses originating from an area distal to the His Purkinje system. VPCs are the most ...
  52. [52]
    Overview of Cardiac Arrhythmias and Treatment Strategies - PMC
    Jun 6, 2023 · Ischemic heart disease is a major contributor to cardiac arrhythmias, which can be life threatening in patients [58]. Ischemic injury causes ...Missing: hyperkalemia | Show results with:hyperkalemia
  53. [53]
    Mechanisms of Arrhythmias and Conduction Disorders in Older Adults
    Aging is associated with an increased prevalence of cardiac arrhythmias, which contribute to higher morbidity and mortality in the elderly.
  54. [54]
    Electrophysiology of Hypokalemia and Hyperkalemia | Circulation
    Mar 17, 2017 · In this article, we discuss the basic science underlying the effects of both hypo- and hyperkalemia on cardiac excitability and arrhythmias.
  55. [55]
    Electrocardiogram - StatPearls - NCBI Bookshelf - NIH
    The electrocardiogram (abbreviated as ECG or EKG) represents an electrical tracing of the heart and is recorded non-invasively from the surface of the body.Introduction · Anatomy and Physiology · Equipment · Clinical Significance
  56. [56]
    Conduction Disorders: The Value of Surface ECG - PMC
    Surface ECG allows the diagnosis of atrioventricular and intraventricular conduction disorder and its anatomical block site most of the time.
  57. [57]
    Electrophysiologic Study Interpretation - StatPearls - NCBI Bookshelf
    Mar 28, 2025 · EPS involves using intracardiac catheters to assess electrical conduction, identify arrhythmia mechanisms, and guide therapeutic interventions.
  58. [58]
    Electrophysiologic Study Indications and Evaluation - NCBI - NIH
    Apr 3, 2023 · An electrophysiology study is performed for the identification of arrhythmias and risk stratification of patients at risk of sudden cardiac death.
  59. [59]
    State-of-the-Art Imaging of Infiltrative Cardiomyopathies
    Nov 2, 2023 · This review will highlight the role of cardiac imaging, including echocardiography, cardiac magnetic resonance imaging (CMR), and nuclear ...
  60. [60]
    Imaging tools for assessment of myocardial fibrosis in humans
    In this article, we will first review current medical imaging technologies for assessing fibrosis including echo and MRI.
  61. [61]
    Prevalence of cardiac fibrosis and infiltrative cardiomyopathy in ...
    Jul 6, 2025 · Cardiac MRI may be an important adjunctive tool for the investigation of conduction disease, particularly in younger patients.
  62. [62]
    Beta-blockers in cardiac arrhythmias–Clinical pharmacologist's point ...
    β-blockers can also be used in regular wide–QRS complex tachycardias, but only in case of SVT with aberrant conduction. When the mechanism of arrhythmia is ...
  63. [63]
    Antiarrhythmic Medications - StatPearls - NCBI Bookshelf - NIH
    Antiarrhythmic medications play a pivotal role in managing various cardiac rhythm disorders, and their classification under the Vaughan-Williams system ...Missing: pharmacotherapy | Show results with:pharmacotherapy
  64. [64]
    Modernized Classification of Cardiac Antiarrhythmic Drugs
    Oct 22, 2018 · Class II drugs, comprising β-adrenergic inhibitors, reduce sino-atrial node (SAN) pacing rates and slow atrioventricular node (AVN) AP ...
  65. [65]
    Pacemaker Insertion - StatPearls - NCBI Bookshelf
    Oct 6, 2024 · [11]. Bundle of His: The bundle of His is a thin structure with specialized conduction cells connecting the distal part of the compact ...
  66. [66]
    Electrophysiology Study and Ablation of Atrioventricular Nodal ...
    Jul 30, 2023 · This activity reviews the role of electrophysiology study and catheter ablation in the diagnosis and treatment of AVNRT.
  67. [67]
    Atrioventricular Block During Slow Pathway Ablation | Circulation
    Jun 1, 2015 · The patient underwent permanent pacemaker implantation after the ablation procedure as there was no recovery of AV conduction. Open in ...
  68. [68]
    Conduction System Pacing: Where Are We in 2025? - PMC - NIH
    In particular, LB pacing appears to be the most clinically applicable therapy as it avoids the disadvantages of His-bundle pacing (sensing challenges, higher ...Missing: 2020-2025 | Show results with:2020-2025
  69. [69]
    Gene Therapy in Cardiovascular Disease: Recent Advances and ...
    Nov 11, 2024 · Multiple early-phase clinical trials are ongoing to examine the safety and efficacy of gene replacement and genome editing through viral and ...
  70. [70]
    Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and ...
    Jul 30, 2025 · Gene therapy has emerged as a transformative approach, offering precise and durable interventions that directly target the arrhythmogenic ...